Cleared Traditional

K121993 - SPECTRALIS HRA + OCT AND VARIANTS, SPECTRALIS FA+ OCT, SPECTRALIS ICGA +OCT, SPECTRALIS OCT BLUE PEAK, SPECTRALIS OCT (FDA 510(k) Clearance)

Oct 2012
Decision
111d
Days
Class 2
Risk

K121993 is an FDA 510(k) clearance for the SPECTRALIS HRA + OCT AND VARIANTS, SPECTRALIS FA+ OCT, SPECTRALIS ICGA +OCT, SPECTRALIS OCT BLUE PEAK, SPECTRALIS OCT. This device is classified as a Tomography, Optical Coherence (Class II - Special Controls, product code OBO).

Submitted by Heidelberg Engineering GmbH (Fairfax, US). The FDA issued a Cleared decision on October 25, 2012, 111 days after receiving the submission on July 6, 2012.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.1570. Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases..

Submission Details

510(k) Number K121993 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 2012
Decision Date October 25, 2012
Days to Decision 111 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code OBO - Tomography, Optical Coherence
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.1570
Definition Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases.